Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS

Launched by DR. MED. CHRISTIAN ROTHERMUNDT · Aug 28, 2014

Keywords

ClinConnect Summary

The Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS) is researching how to better follow and care for patients diagnosed with testicular cancer. This study aims to understand how often and in what ways testicular cancer can come back after treatment. It will also look at the long-term effects that treatment can have on health, such as heart problems, hormone issues, and even the risk of developing other cancers. By gathering this information, the study hopes to improve follow-up care and recommendations for patients, ensuring they receive the best possible support and monitoring.

To participate in this study, individuals must be men aged 18 and older who have been diagnosed with testicular cancer and have completed their treatment within the last six months. They should be willing to attend regular check-ups as part of the study. Those who have had another type of cancer in the last five years or who cannot meet the study requirements will not be eligible. Participants can expect to undergo routine tests and check-ups that will help doctors learn more about managing testicular cancer effectively and safely.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Written informed consent.
• • Histologically proven seminomas or non-seminoma.
• • Seminoma: complete remission (CR) or lymph nodes (LN) \< 3cm or PET negative partial remission (PR) or non-seminoma: CR.
• • Completion of treatment within the last 6 months.
• • Patient able and willing to attend for regular surveillance.
• Exclusion Criteria:
• • Co-existent malignancy within 5 years.
• • Inability for any reason to comply with the trial investigations or follow-up schedules.